Enyo Pharma
Developing therapeutics for diseases with impaired kidney function
Lyon, France · Founded 2014 · $110.5M raised
- Headquarters
- Lyon
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- enyopharma.com
- Total Funding
- $110.5M
- Last Round
- $42.5M Series CJan 2024
- Rounds
- 3
About
ENYO Pharma is a clinical-stage biopharma company in Lyon, France. Founded 2014. Lead compound VONAFEXOR in Phase 2 for Alport Syndrome and CKD.
Summary
Enyo Pharma is a Biotech company based in Lyon, France, founded in 2014. It has raised $110.5M in total across 3 rounds, most recently a $42.5M Series C round in Jan 2024. Investors include Vesalius Biocapital IV, OrbiMed and Andera Partners.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company